Yehuda Rachel
The Traumatic Stress Studies Program, Department of Psychiatry, The Mount Sinai School of Medicine, New York, New York, USA.
Ann N Y Acad Sci. 2009 Oct;1179:56-69. doi: 10.1111/j.1749-6632.2009.04979.x.
The current status of glucocorticoid alterations in post-traumatic stress disorder (PTSD) will be described in this chapter. Emphasis will be placed on data that suggest that at least some glucocorticoid-related observations in PTSD reflect pretraumatic glucocorticoid status. Recent observations have provided some evidence that pretraumatic glucocorticoid alterations may arise from genetic, epigenetic, and possibly other environmental influences that serve to increase the likelihood of developing PTSD following trauma exposure, as well as modulate attendant biological alterations associated with its pathophysiology. Current studies in the field of PTSD employ glucocorticoid challenge strategies to delineate effects of exogenously administered glucocorticoids on neuroendocrine, cognitive, and brain function. Results of these studies have provided an important rationale for using glucocorticoid strategies in the treatment of PTSD.
本章将阐述创伤后应激障碍(PTSD)中糖皮质激素变化的现状。重点将放在一些数据上,这些数据表明,PTSD中至少某些与糖皮质激素相关的观察结果反映了创伤前的糖皮质激素状态。最近的观察提供了一些证据,表明创伤前糖皮质激素变化可能源于遗传、表观遗传以及其他可能的环境影响,这些影响会增加创伤暴露后发生PTSD的可能性,并调节与其病理生理学相关的伴随生物学变化。PTSD领域的当前研究采用糖皮质激素激发策略来描述外源性给予糖皮质激素对神经内分泌、认知和脑功能的影响。这些研究结果为在PTSD治疗中使用糖皮质激素策略提供了重要依据。